Presentation is loading. Please wait.

Presentation is loading. Please wait.

Changing the Paradigm of Treatment in Patients With Hodgkin Lymphoma

Similar presentations


Presentation on theme: "Changing the Paradigm of Treatment in Patients With Hodgkin Lymphoma"— Presentation transcript:

1 Changing the Paradigm of Treatment in Patients With Hodgkin Lymphoma

2 Outline of the Program

3 Statistics

4 Pathology

5 Cellular Interactions in the Microenvironment

6 Clinical Significance of the Tumor Microenvironment

7

8

9

10

11

12

13 Preventing Immune Escape Targeting CD30 With Brentuximab Vedotin

14

15

16

17

18 How Does Immune Checkpoint Blockade work? Blocking PD-1

19

20

21

22

23

24

25

26 Nivolumab Durability of Response

27 Nivolumab: Treatment-Related AEs

28

29 Pembrolizumab Durability of Response

30

31 PD-L1 Expression

32 Phase 2 Data With PD-1 Blockade: Nivolumab

33 Phase 2 Data With PD-1 Blockade: Pembrolizumab

34

35 ECHELON-1: ABVD vs AVD+BV as Frontline Therapy in Stage III/IV HL

36 Combination Approaches Brentuximab Vedotin + Ipilimumab

37 Conclusions

38 Abbreviations

39 Abbreviations (cont)

40 Abbreviations (cont)

41 Abbreviations (cont)


Download ppt "Changing the Paradigm of Treatment in Patients With Hodgkin Lymphoma"

Similar presentations


Ads by Google